These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15974937)
1. Recent advances in neuromuscular blocking agents. Zlotos DP Mini Rev Med Chem; 2005 Jun; 5(6):595-606. PubMed ID: 15974937 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of neuromuscular blocking agents. Tuba Z; Maho S; Vizi ES Curr Med Chem; 2002 Aug; 9(16):1507-36. PubMed ID: 12171561 [TBL] [Abstract][Full Text] [Related]
3. The new neuromuscular blocking agents: do they offer any advantages? Moore EW; Hunter JM Br J Anaesth; 2001 Dec; 87(6):912-25. PubMed ID: 11878696 [TBL] [Abstract][Full Text] [Related]
4. Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents. Booij LH Pharm World Sci; 1997 Feb; 19(1):13-34. PubMed ID: 9089750 [TBL] [Abstract][Full Text] [Related]
5. Development of ultra short-acting muscle relaxant agents: history, research strategies, and challenges. Gyermek L Med Res Rev; 2005 Nov; 25(6):610-54. PubMed ID: 16086361 [TBL] [Abstract][Full Text] [Related]
6. Quaternary derivatives of granatanol diesters: potent, ultrashort acting non-depolarizing neuromuscular relaxants. Gyermek L; Lee C; Cho YM; Nguyen N Life Sci; 2006 Jul; 79(6):559-69. PubMed ID: 16516930 [TBL] [Abstract][Full Text] [Related]
8. Pharmacology of G-1-64, a new nondepolarizing neuromuscular blocking agent with rapid onset and short duration of action. Gyermek L; Lee C; Nguyen N Acta Anaesthesiol Scand; 1999 Jul; 43(6):651-7. PubMed ID: 10408820 [TBL] [Abstract][Full Text] [Related]
9. A new short-acting non-depolarizing muscle relaxant (SZ1677) without cardiovascular side-effects. Vizi ES; Tuba Z; Mahó S; Foldes FF; Nagano O; Dóda M; Takagi S; Chaudhry IA; Saubermann AJ; Nagashima H Acta Anaesthesiol Scand; 2003 Mar; 47(3):291-300. PubMed ID: 12648195 [TBL] [Abstract][Full Text] [Related]
10. Non-depolarizing neuromuscular blocking activity of bisquaternary amino di- and tripeptide derivatives. Booij LH; van der Broek LA; Caulfield W; Dommerholt-Caris BM; Clark JK; van Egmond J; McGuire R; Muir AW; Ottenheijm HC; Rees DC J Med Chem; 2000 Dec; 43(25):4822-33. PubMed ID: 11123992 [TBL] [Abstract][Full Text] [Related]
12. Neuromuscular blockers in surgery and intensive care, Part 2. McManus MC Am J Health Syst Pharm; 2001 Dec; 58(24):2381-95. PubMed ID: 11794954 [TBL] [Abstract][Full Text] [Related]
13. Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats. Hughes R; Chapple DJ Br J Anaesth; 1976 Feb; 48(2):59-68. PubMed ID: 130154 [TBL] [Abstract][Full Text] [Related]
15. The neuromuscular blocking effect of trimetaphan alone and in combination with different non-depolarizing muscle relaxants in the rat. Pollard BJ; van der Spek AF J Pharm Pharmacol; 1987 Nov; 39(11):896-9. PubMed ID: 2892913 [TBL] [Abstract][Full Text] [Related]
16. Neuromuscular blockers in surgery and intensive care, Part 1. McManus MC Am J Health Syst Pharm; 2001 Dec; 58(23):2287-99. PubMed ID: 11763807 [TBL] [Abstract][Full Text] [Related]
18. Neuromuscular pharmacology of TAAC3, a new nondepolarizing muscle relaxant with rapid onset and ultrashort duration of action. Gyermek L; Lee C; Cho YM; Nguyen N; Tsai SK Anesth Analg; 2002 Apr; 94(4):879-85, table of contents. PubMed ID: 11916790 [TBL] [Abstract][Full Text] [Related]
19. Recent advances in neuromuscular blocking agents. Bartkowski RR Am J Health Syst Pharm; 1999 Jun; 56(11 Suppl 1):S14-7. PubMed ID: 10437712 [TBL] [Abstract][Full Text] [Related]
20. 3,16-Bisquaternary ammonium steroid derivatives as neuromuscular blocking agents: synthesis and biological evaluation. Hu H; Rao Z; Feng M; Wu Z; Xu J; Chen H; Liu P; Xiao Y; Hong X; Hu X; Ke X Steroids; 2015 Apr; 96():103-14. PubMed ID: 25637675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]